The second MidWest Drug Development conference held last month was another resounding success.
The conference featured 42 technology presentations from 18 Midwestern universities, and 30 different companies and investor groups. An estimated 240 one-on-one partnering meetings were held during the two-day event, opening the door to additional opportunities for each participating university.
“I know we got a lot of value out of the conference, and I’ve had nothing but positive feedback from just about everyone I talked to,” said Matt Boehm, the event coordinator and director of licensing for UNeMed, the technology transfer and commercialization office for the University of Nebraska Medical Center. UNeMed is also the primary sponsor and host of the event.
Boehm added that he sat in on 17 one-on-one partnering meetings during the event, resulting in ongoing conversations that may yet lead to further development.
“That’s exactly what we want this conference to do,” UNeMed president and CEO Michael Dixon said. “New therapies, treatments and cures are the kind of things that can grow out of those deeper conversations. And, honestly, I think there’s a huge blind spot for the innovation that happens in the Midwest, and we really want this conference to help change that. Not just for us in Nebraska, but for all our friends in the region.”
The goal of the Midwest Drug Development conference is to provide industry and investors a single event to learn about cutting edge Midwestern therapeutic technologies and start-up companies.
The 2019 MWDD conference will offer feature technologies from most major Midwestern universities, including Nebraska and the Nebraska Medical Center, Kansas, Kansas State, Iowa, Iowa State, Iowa, Mayo Clinic, Note Dame, Kentucky, Cincinnati Children’s, Missouri, Oklahoma, Purdue and Colorado.
Ample spaces dedicated to networking will be available for university, industry and investor guests who want to engage in one-on-one partnering discussions regarding their technologies.
Major medical research and research institutions in Midwestern states will bring their best and brightest
Top decision makers from the world’s leading pharmaceutical companies and investment groups will gather for a look at the most promising therapeutic discoveries and innovations in the Midwest United States
OMAHA, Nebraska (January 6, 2020)—Due the continued success and popularity of the MidWest Drug Development Conference, the event will return for a third year and registrations are now open, planners announced today.
The conference will again span two days, featuring Midwestern university technologies, beginning on Monday, Oct. 5, and concluding the following day, Tuesday, Oct. 6. The same venue—the Capital District Marriott in downtown Omaha—will house the event.
OMAHA, Nebraska (November 18, 2019)—The second MidWest Drug Development conference held last month was another resounding success.
The conference featured 42 technology presentations from 18 Midwestern universities, and 30 different companies and investor groups. An estimated 240 one-on-one partnering meetings were held during the two-day event, opening the door to additional opportunities for each participating university.
Due to an unexpected level of interest, only a handful of waivers remain for the 2019 MidWest Drug Development Conference.
Hotel website: http://www.downtownomahamarriott.com/
Event Coordinators
matt@mwdrugdevelopment.com | 402-559-2468
michael@mwdrugdevelopment.com | 402-559-2468
